Time Source Company Announcement
06 Mar 2023 07:00 AM Holding(s) in Company
06 Mar 2023 07:00 AM PDMR Dealings
06 Mar 2023 07:00 AM Directorate Change
06 Mar 2023 07:00 AM Enhertu DESTINY-PanTumor02 shows positive results
06 Mar 2023 07:00 AM Holding(s) in Company
06 Mar 2023 07:00 AM Intended Appointment of Non-Executive Director
06 Mar 2023 07:00 AM Appointment of Dr Graham Cooley to Chair H2 Green
06 Mar 2023 07:00 AM Costain Civil Engineering Project
06 Mar 2023 07:00 AM Notice of Results
06 Mar 2023 07:00 AM Notice of Results
06 Mar 2023 07:00 AM Director/PDMR Shareholding
06 Mar 2023 07:00 AM Notice of results and Investor presentation
06 Mar 2023 07:00 AM Notice of Investor Presentation
06 Mar 2023 07:00 AM Notice of Results
06 Mar 2023 07:00 AM Directors' Dealings
06 Mar 2023 07:00 AM Holding(s) in Company
06 Mar 2023 07:00 AM Kepler Trust Intelligence: New Research
06 Mar 2023 07:00 AM Change of Advisor
06 Mar 2023 07:00 AM Grant of Options and Director/PDMR Dealing
06 Mar 2023 07:00 AM Acquisition of Fourways Vehicle Solutions
06 Mar 2023 07:00 AM Capital Markets Day Webinar Recording
06 Mar 2023 07:00 AM Change of Adviser
06 Mar 2023 07:00 AM Kepler Trust Intelligence: New Research
06 Mar 2023 07:00 AM Kepler Trust Intelligence: New Research
06 Mar 2023 07:00 AM Kepler Trust Intelligence: New Research
06 Mar 2023 07:00 AM Investor Presentation
06 Mar 2023 07:00 AM Sale of JFN, Trading Update and Notice of Results
06 Mar 2023 07:00 AM MSALABS Trading Update
06 Mar 2023 07:00 AM Update re TSHII
06 Mar 2023 07:00 AM Statement re Press Comment
06 Mar 2023 07:00 AM Tenant update
06 Mar 2023 07:00 AM Grant of Option - Lithium Claim Block
06 Mar 2023 07:00 AM Trading Update
06 Mar 2023 07:00 AM Trading Update and Notice of Results
06 Mar 2023 07:00 AM Interim Results
06 Mar 2023 07:00 AM Transaction in Own Shares
06 Mar 2023 07:00 AM Blythe H2 well spud
06 Mar 2023 07:00 AM 2022 Year-End Reserves
06 Mar 2023 07:00 AM Response to press speculation
06 Mar 2023 07:00 AM Transaction in Own Shares
06 Mar 2023 07:00 AM Acquisition
06 Mar 2023 07:00 AM Full Year Results
06 Mar 2023 07:00 AM Results for the half year ended 31 December 2022
06 Mar 2023 07:00 AM 2022 Annual Recap and Fund Results
06 Mar 2023 07:00 AM Collaboration with Orano on ImmuPharma Peptide
06 Mar 2023 07:00 AM Transaction in Own Shares
06 Mar 2023 07:00 AM Preliminary results
06 Mar 2023 07:00 AM Araguaia Line2 Feasibility Study Contracts Awarded
06 Mar 2023 07:00 AM Fibre Controller Contracts Progress
06 Mar 2023 07:00 AM Formation of Scientific Advisory Board
UK 100

Latest directors dealings